Cao W, Liu R, Zhao W, Li J, Wang Y, Yuan X
Mar Drugs. 2024; 22(7).
PMID: 39057414
PMC: 11277839.
DOI: 10.3390/md22070305.
Gonzalez-Alsina A, Mateu-Borras M, Domenech-Sanchez A, Alberti S
Microorganisms. 2023; 11(3).
PMID: 36985237
PMC: 10056308.
DOI: 10.3390/microorganisms11030664.
Ghaly M, Albalawi M, Bendary M, Shahin A, Shaheen M, Abu Eleneen A
Antibiotics (Basel). 2023; 12(3).
PMID: 36978330
PMC: 10044421.
DOI: 10.3390/antibiotics12030464.
Everett M, Davies D, Leiris S, Sprynski N, Llanos A, Castandet J
ACS Infect Dis. 2023; 9(2):270-282.
PMID: 36669138
PMC: 9926489.
DOI: 10.1021/acsinfecdis.2c00418.
Saraeva I, Tolordava E, Yushina Y, Sozaev I, Sokolova V, Khmelnitskiy R
Nanomaterials (Basel). 2022; 12(21).
PMID: 36364634
PMC: 9657403.
DOI: 10.3390/nano12213857.
The Structures and Binding Modes of Small-Molecule Inhibitors of Elastase LasB.
Camberlein V, Jezequel G, Haupenthal J, Hirsch A
Antibiotics (Basel). 2022; 11(8).
PMID: 36009930
PMC: 9404851.
DOI: 10.3390/antibiotics11081060.
Structural bioinformatic analysis of DsbA proteins and their pathogenicity associated substrates.
Santos-Martin C, Wang G, Subedi P, Hor L, Totsika M, Paxman J
Comput Struct Biotechnol J. 2021; 19:4725-4737.
PMID: 34504665
PMC: 8405906.
DOI: 10.1016/j.csbj.2021.08.018.
Human Single-Chain Antibodies That Neutralize Elastolytic Activity of LasB.
Santajit S, Kong-Ngoen T, Chongsa-Nguan M, Boonyuen U, Pumirat P, Sookrung N
Pathogens. 2021; 10(6).
PMID: 34204417
PMC: 8234315.
DOI: 10.3390/pathogens10060765.
Seeing the PDB.
Richardson J, Richardson D, Goodsell D
J Biol Chem. 2021; 296:100742.
PMID: 33957126
PMC: 8167287.
DOI: 10.1016/j.jbc.2021.100742.
Inhibition of bacterial and human zinc-metalloproteases by bisphosphonate- and catechol-containing compounds.
Rahman F, Nguyen T, Adekoya O, Campestre C, Tortorella P, Sylte I
J Enzyme Inhib Med Chem. 2021; 36(1):819-830.
PMID: 33757387
PMC: 7993378.
DOI: 10.1080/14756366.2021.1901088.
Characterization of Putative Virulence Factors of Strain RBS Isolated from a Saltern, Tunisia: Effect of Metal Ion Cofactors on the Structure and the Activity of LasB.
Rigane E, Dutoit R, Matthijs S, Brandt N, Flahaut S, Belghith K
Biomed Res Int. 2020; 2020:6047528.
PMID: 32775429
PMC: 7396000.
DOI: 10.1155/2020/6047528.
Structural Requirements of -alpha-Mercaptoacetyl Dipeptide (NAMdP) Inhibitors of Virulence Factor LasB: 3D-QSAR, Molecular Docking, and Interaction Fingerprint Studies.
Velazquez-Libera J, Murillo-Lopez J, F de la Torre A, Caballero J
Int J Mol Sci. 2019; 20(24).
PMID: 31817391
PMC: 6940830.
DOI: 10.3390/ijms20246133.
Contact lens-related corneal infection: Intrinsic resistance and its compromise.
Fleiszig S, Kroken A, Nieto V, Grosser M, Wan S, Metruccio M
Prog Retin Eye Res. 2019; 76:100804.
PMID: 31756497
PMC: 7237316.
DOI: 10.1016/j.preteyeres.2019.100804.
Calcium Regulation of Bacterial Virulence.
King M, Kayastha B, Franklin M, Patrauchan M
Adv Exp Med Biol. 2019; 1131:827-855.
PMID: 31646536
PMC: 7473484.
DOI: 10.1007/978-3-030-12457-1_33.
Disarming Virulence by the Inhibitory Action of 1,10-Phenanthroline-5,6-Dione-Based Compounds: Elastase B (LasB) as a Chemotherapeutic Target.
Galdino A, Viganor L, de Castro A, da Cunha E, Mello T, Mattos L
Front Microbiol. 2019; 10:1701.
PMID: 31428062
PMC: 6688126.
DOI: 10.3389/fmicb.2019.01701.
Targeting Metalloenzymes for Therapeutic Intervention.
Chen A, Adamek R, Dick B, Credille C, Morrison C, Cohen S
Chem Rev. 2018; 119(2):1323-1455.
PMID: 30192523
PMC: 6405328.
DOI: 10.1021/acs.chemrev.8b00201.
Effects of Glycosylation on the Enzymatic Activity and Mechanisms of Proteases.
Goettig P
Int J Mol Sci. 2016; 17(12).
PMID: 27898009
PMC: 5187769.
DOI: 10.3390/ijms17121969.
The LasB Elastase of Pseudomonas aeruginosa Acts in Concert with Alkaline Protease AprA To Prevent Flagellin-Mediated Immune Recognition.
Casilag F, Lorenz A, Krueger J, Klawonn F, Weiss S, Haussler S
Infect Immun. 2015; 84(1):162-71.
PMID: 26502908
PMC: 4693985.
DOI: 10.1128/IAI.00939-15.
Mechanistic insights into elastin degradation by pseudolysin, the major virulence factor of the opportunistic pathogen Pseudomonas aeruginosa.
Yang J, Zhao H, Ran L, Li C, Zhang X, Su H
Sci Rep. 2015; 5:9936.
PMID: 25905792
PMC: 4407726.
DOI: 10.1038/srep09936.
Identification of Pseudolysin (lasB) as an Aciduric Gluten-Degrading Enzyme with High Therapeutic Potential for Celiac Disease.
Wei G, Tian N, Valery A, Zhong Y, Schuppan D, Helmerhorst E
Am J Gastroenterol. 2015; 110(6):899-908.
PMID: 25895519
PMC: 4461489.
DOI: 10.1038/ajg.2015.97.